4556.T Stock: KAINOS Laboratories, Inc. Stock Price, Analysis & Insights
Get live 4556.T stock price $2268.00, comprehensive KAINOS Laboratories, Inc. stock analysis, charts, news, and expert forecast. Real-time 4556.T stock data and investment insights.
Loading chart data...
KAINOS Laboratories, Inc. (4556.T) Overview
KAINOS Laboratories, Inc. (4556.T) is a publicly traded company in the Healthcare sector , specifically within the Medical - Instruments & Supplies industry . As of the latest trading session, 4556.T trades at $2268.00 with a market capitalization of 10.10B . Over the past 52 weeks, 4556.T has traded between $1204.00 and $2284.00 , with the current price positioned at approximately 99% of this ...
Key Takeaways
- Operates in the Healthcare sector (Medical - Instruments & Supplies)
- Market cap: 10.10B
- Current price: $2268.00
- 52-week range: $1204.00 - $2284.00
- P/E ratio: 21.37
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Based in Tokyo, Japan, KAINOS Laboratories, Inc. specializes in the research, development, production, commercialization, and global trade of various items. Its extensive portfolio encompasses pharmaceuticals, diagnostic agents, and associated chemic...
Company Information
- CEO
- Yukihiro Nagatsu
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 133
Contact Information
- Website
- https://www.kainos.co.jp
- Address
- 38-18, Hongo 2-chome
- Country
- JP
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 21.4)
✓ Lower volatility stock (Beta: 0.44) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for KAINOS Laboratories, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for KAINOS Laboratories, Inc.
- ⚠Investors should consider how KAINOS Laboratories, Inc. fits within their overall portfolio allocation
Market Cap
10.10B
P/E Ratio (TTM)
21.37
Beta
0.44
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare 4556.T with peer companies:
- Price
- $132.00-1.49% (1D)
- Market cap
- 4.88B
- Price
- $2,178.00+1.44% (1D)
- Market cap
- 4.85B
- Price
- $68.00+1.49% (1D)
- Market cap
- 3.26B
- Price
- $70.00-1.41% (1D)
- Market cap
- 3.86B
- Price
- $537.00-0.56% (1D)
- Market cap
- 4.53B
- Price
- $1,170.00-0.85% (1D)
- Market cap
- 5.25B
- Price
- $192.00-2.54% (1D)
- Market cap
- 5.27B
- Price
- $471.00-0.42% (1D)
- Market cap
- 3.07B
- Price
- $795.00+1.27% (1D)
- Market cap
- 5.65B
- Price
- $676.00+2.11% (1D)
- Market cap
- 6.63B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
43/100 ⭐⭐⭐
- Overall
- -1.0%
- NYSE
- -1.6%
- NASDAQ
- -0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.3% | +1.3% | +1.9% | 19.8 | 83/100⭐⭐⭐⭐⭐ |
| Technology | +0.8% | +1.1% | +3.0% | 52.0 | 76/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.8% | +0.3% | +1.9% | 27.9 | 69/100⭐⭐⭐⭐ |
| Industrials | -0.3% | -0.9% | +2.7% | 43.0 | 64/100⭐⭐⭐⭐ |
| Communication Services | -0.8% | -1.3% | +0.4% | 21.9 | 48/100⭐⭐⭐ |
| Consumer Defensive | +0.6% | +1.6% | -2.5% | 31.2 | 44/100⭐⭐⭐ |
| Healthcare | -1.0% | -2.0% | +1.5% | 30.5 | 43/100⭐⭐⭐ |
| Real Estate | +0.5% | -1.1% | -0.0% | 50.0 | 33/100⭐⭐ |
| Energy | +0.5% | -3.6% | -0.0% | 35.9 | 31/100⭐⭐ |
| Utilities | +2.0% | -1.3% | -5.1% | 26.1 | 31/100⭐⭐ |
| Consumer Cyclical | -0.3% | +0.3% | -0.2% | 55.8 | 28/100⭐⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-13.